glp-1 for nash Receptor Agonist and Non-Alcoholic Fatty Liver Disease Possible hepatoprotective effects of GLP-1
Description
GLP-1 has a very short half-life of approximately 1-2 minutes in circulation, as it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4)
Diabetes (2001) 50:25407.10.2337/diabetes.50.11.2540 19 TongJPrigeonRLDavisHWBidlingmaierMKahnSECummingsDEet alGhrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans
Novel gut afferents: intrinsic afferent neurons and intestinofugal neurons
Hausenblas HA et al
General Inquiry HAVE A QUESTION
